GlycoMimetics: A Cancer-Cure Lottery Ticket Grabbing My Attention (NASDAQ:GLYC)
FatCamera/E+ via Getty Images A powerfully bullish chart pattern from late 2022 is found in the trading of small biotech research firm GlycoMimetics, Inc. (NASDAQ:GLYC). A flood of buying occurred when the company announced in […]
